Fortunately, recent studies have identified somatic mutation in the isocitrate dehydrogenase 1 and 2 (IDH 1 and 2) as well as Telomerase Reverse Transcriptase (TERT) promoter genes which present over 80% of glioma (Kurimoto et al., 2016). Here, TERT is linked to central nervous system cancer.